Breaking News Instant updates and real-time market news.

CNAT

Conatus

$1.96

-0.04 (-2.00%)

16:15
10/03/16
10/03
16:15
10/03/16
16:15

Conatus announces acceptance of Emricasan abstracts for AASLD annual meeting

Conatus Pharmaceuticals announced that abstracts for four posters - two addressing clinical results and two addressing preclinical results with the company's pan-caspase inhibitor, emricasan - have been accepted for presentation at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, AASLD, in Boston November 11-15.

CNAT Conatus
$1.96

-0.04 (-2.00%)

05/09/16
BMUR
05/09/16
NO CHANGE
Target $7
BMUR
Buy
Conatus price target lowered to $7 from $13 at Brean Capital
Brean Capital lowered its price target on Conatus to $7 from $13 as the firm believes data from its Phase ll liver cirrhosis study has yielded inconclusive results. Brean Capital lowered its price target based on cutting the probability of success for emricasan in liver cirrhosis to 20% from 30%. Brean Capital maintained its Buy rating on Conatus shares, as they believe the company remains on the forefront of developing liver disease treatments.
07/01/16
ROTH
07/01/16
INITIATION
Target $4
ROTH
Buy
Conatus coverage resumed with a Buy at Roth Capital
Roth Capital analyst Sa'ar Yaniv resumed coverage of Conatus with a Buy rating and $4 price target.
08/29/16
HCWC
08/29/16
NO CHANGE
Target $15
HCWC
Buy
Conatus drug further validated by collaboration, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce keeps a Buy rating on Conatus Pharmaceuticals following the company's collaboration agreement with Exalenz Biosciences. The analyst remains positive on Conatus's prospects in non-alcoholic steatohepatitis cirrhosis. The collaboration brings the use of Exalenz's BreathID Methacetin Breath Test to monitor patients in the upcoming Phase 2b trial evaluating the safety and efficacy of emricasan in 160 patients with liver cirrhosis associated with NASH and severe portal hypertension, Arce tells investors in a research note. Using a "simple and non-invasive test provides not only further scientific validation of emricasan for the treatment of NASH cirrhosis, but it also serves as the first non-invasive test that can assist clinicians to conveniently and cost-effectively monitor the effect of the drug at the point of care," the analyst writes. He has a Buy rating on Conatus with a $15 price target.
09/20/16
STFL
09/20/16
NO CHANGE
Target $6
STFL
Buy
Stifel says Conatus emricasan an interesting asset amid increased focus on NASH
Following Allergan's (AGN) acquisition of small-cap NASH play Tobira (TBRA), Stifel analyst Stephen Willey notes there are some "interesting" similarities between Conatus (CNAT) and the latter. However, the analyst points out that the clearest distinctions between the two are Conatus' emphasis on some of the downstream consequences of NASH fibrosis and the amount of meaningful clinical data generated to date. Willey still thinks Conatus' emricasan is an interesting asset, but urges investors seeking Tobira-like premiums to exercise a level of caution. He reiterates a Buy rating and $6 price target on Conatus' shares. In afternoon trading, shares of Conatus have gained about 20% to $2.10.

TODAY'S FREE FLY STORIES

ICPT

Intercept

$61.59

-12.11 (-16.43%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Recommendations
Intercept analyst commentary  »

Intercept recent weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

YNDX

Yandex

$33.20

0.57 (1.75%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Options
Yandex put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUS

ePlus

$88.60

1.05 (1.20%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Conference/Events
ePlus management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

PKY

Parkway

$23.04

0.02 (0.09%)

12:55
09/25/17
09/25
12:55
09/25/17
12:55
Conference/Events
Parkway to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MOH

Molina Healthcare

$64.59

-0.735 (-1.13%)

, UNH

UnitedHealth

$191.32

-1.7138 (-0.89%)

12:50
09/25/17
09/25
12:50
09/25/17
12:50
Periodicals
Sen. Ted Cruz still opposes Graham-Cassidy bill, Axios reports »

Senator Ted Cruz remains…

MOH

Molina Healthcare

$64.59

-0.735 (-1.13%)

UNH

UnitedHealth

$191.32

-1.7138 (-0.89%)

CNC

Centene

$90.60

-1.62 (-1.76%)

WCG

WellCare

$165.67

-1.49 (-0.89%)

CI

Cigna

$181.69

-1.05 (-0.57%)

ANTM

Anthem

$182.89

0.03 (0.02%)

HNT

Health Net

HUM

Humana

$238.48

-0.6125 (-0.26%)

AET

Aetna

$152.55

-1.02 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

SOL

ReneSola

$2.17

-0.0508 (-2.29%)

12:49
09/25/17
09/25
12:49
09/25/17
12:49
Hot Stocks
ReneSola agrees to disposition of manufacturing, LED distribution units »

ReneSola announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEX

Alexander & Baldwin

$45.23

0.26 (0.58%)

12:49
09/25/17
09/25
12:49
09/25/17
12:49
Conference/Events
Alexander & Baldwin management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

FB

Facebook

$170.54

-0.57 (-0.33%)

12:47
09/25/17
09/25
12:47
09/25/17
12:47
Periodicals
China blocks WhatsApp ahead of Communist Party gathering, NY Times reports »

China has mostly blocked…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

HES

Hess Corp.

$45.45

0.95 (2.13%)

12:45
09/25/17
09/25
12:45
09/25/17
12:45
Options
Hess Corp. call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

C

Citi

$70.60

-0.8 (-1.12%)

12:43
09/25/17
09/25
12:43
09/25/17
12:43
Hot Stocks
Citibank, CGML ordered to pay $550,000 penalty by CFTC »

The U.S. Commodity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

UFPI

Universal Forest

$94.65

2.47 (2.68%)

12:41
09/25/17
09/25
12:41
09/25/17
12:41
Conference/Events
Universal Forest management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

NAV

Navistar

$42.09

0.755 (1.83%)

, VLKAY

Volkswagen

$34.57

0.46 (1.35%)

12:40
09/25/17
09/25
12:40
09/25/17
12:40
Periodicals
Breaking Periodicals news story on Navistar, Volkswagen »

Navistar, Volkswagen…

NAV

Navistar

$42.09

0.755 (1.83%)

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 30

    Oct

DRI

Darden

$82.45

-0.43 (-0.52%)

, FDS

FactSet

$167.38

-1.23 (-0.73%)

12:40
09/25/17
09/25
12:40
09/25/17
12:40
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

DRI

Darden

$82.45

-0.43 (-0.52%)

FDS

FactSet

$167.38

-1.23 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

NAV

Navistar

$42.05

0.72 (1.74%)

, VLKAY

Volkswagen

$34.57

0.46 (1.35%)

12:39
09/25/17
09/25
12:39
09/25/17
12:39
Hot Stocks
Navistar announces collaboration with Volkswagen Truck & Bus »

Navistar (NAV) announced…

NAV

Navistar

$42.05

0.72 (1.74%)

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 30

    Oct

F

Ford

$11.88

0.035 (0.30%)

12:38
09/25/17
09/25
12:38
09/25/17
12:38
Periodicals
NFL sponsor Ford issues statement supporting free speech, Bloomberg says »

Following a string of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

  • 26

    Oct

BGG

Briggs & Stratton

$22.70

0.01 (0.04%)

12:35
09/25/17
09/25
12:35
09/25/17
12:35
Conference/Events
Briggs & Stratton management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ICPT

Intercept

$61.59

-12.11 (-16.43%)

12:34
09/25/17
09/25
12:34
09/25/17
12:34
Recommendations
Intercept analyst commentary  »

Jefferies cuts Intercept…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DLAKY

Lufthansa

$27.31

-0.1 (-0.36%)

, MKGAY

Merck KGaA

12:33
09/25/17
09/25
12:33
09/25/17
12:33
Hot Stocks
Lufthansa chairman Mayrhuber resigns, Kley named new chairman »

Prior to today's…

DLAKY

Lufthansa

$27.31

-0.1 (-0.36%)

MKGAY

Merck KGaA

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAWW

Atlas Air

$67.60

0.15 (0.22%)

12:32
09/25/17
09/25
12:32
09/25/17
12:32
Hot Stocks
Atlas Air, Polar Air Cargo seek preliminary injunction to stop work slowdown »

Atlas Air and Polar Air…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIN

Albany International

$55.80

-0.45 (-0.80%)

12:31
09/25/17
09/25
12:31
09/25/17
12:31
Conference/Events
Albany International management to meet with Sidoti »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

, FB

Facebook

$170.54

-0.57 (-0.33%)

12:30
09/25/17
09/25
12:30
09/25/17
12:30
Periodicals
Trump to issue directive to boost government support for STEM, Recode reports »

President Donald Trump…

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

FB

Facebook

$170.54

-0.57 (-0.33%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GM

General Motors

$40.23

0.805 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

FB

Facebook

$170.54

-0.57 (-0.33%)

12:30
09/25/17
09/25
12:30
09/25/17
12:30
Options
Facebook options see heavy volume as shares selloff 4% »

Facebook options see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

SXI

Standex

$102.70

0.1 (0.10%)

12:27
09/25/17
09/25
12:27
09/25/17
12:27
Conference/Events
Standex management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

12:25
09/25/17
09/25
12:25
09/25/17
12:25
Conference/Events
Federal Reserve Bank of Chicago President to speak on economic conditions »

Chicago Federal Reserve…

12:25
09/25/17
09/25
12:25
09/25/17
12:25
General news
Breaking General news story  »

Chicago Federal Reserve…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.